Altogether, these results demonstrate that reduction of ACLY in FD fibroblasts leads to MT acetylation and MT-dependent transport impairments; these molecular defects likely contribute to the pathological mechanisms underlying FD. The gene discussed is ACLY; the disease is Fabry disease.